Discover how AI is transforming DNA and gene design, from expression prediction to generative sequence creation, and why synthesis is what closes the loop.

New tools are extending the gains mRNA vaccines made during COVID-19

Synthetic DNA providers are asking for enforceable biosecurity screening rules. Congress should give them some.

AI is making it easier to design dangerous pathogens. That's real. But our biosecurity system for DNA synthesis needs stronger governance, standards, and incentives for compliance.

20 kb x 20 Teams.Free Clonal DNA. SUBMISSION WINDOW: MAY 25 – JULY 31, 2026 20 kb x 20 Teams.Free Clonal DNA. SUBMISSION WINDOW: MAY 25 – JULY 31, 2026 Ansa is proud to support the 2026 iGEM competiti...

The pace of synthetic biology is accelerating—and with it, the complexity of the DNA constructs researchers are being asked to design, build, and validate. Longer constructs, difficult motifs, and inc...

Webinar Codon Optimization Isn’t Equal: Benchmarking Gene Design for Antibody Expression On-demand Webinar Watch the Webinar Key takeaways include: An AI-powered codon optimization strategy that measu...

Daniel Lin-Arlow launched a company to tackle limitations in DNA synthesis. Today, he serves as the chief scientific officer at Ansa Biotechnologies.

In an exclusive conversation ahead of his appearance at SynBioBeta 2026 on May 4-7th in San Jose, Jason T. Gammack previewed his talk that reframes the synthetic biology bottleneck most researchers ha...

I’m really excited to be joining Ansa Biotechnologies as the company’s chief operating officer. In this role, I’ll be able to use my expertise in DNA and gene synthesis technology and operations to he...

Unlock scientific breakthroughs with our custom DNA synthesis. As a leading enzymatic DNA synthesis company, we deliver speed, accuracy, and longer sequences for biology innovation.

Evo 2 is an artificial intelligence-based biological foundation model trained on 9 trillion DNA base pairs spanning all domains of life that predicts functional properties from genomic sequences and p...

On-demand Webinar Register To Watch Breakthroughs in gene therapy depend on the ability to build and deliver large, complex DNA constructs quickly, reliably, and at scale. Yet constructs over 5 kb, or...

A new system lets researchers build and reprogram phage genomes from digital sequence data, potentially enabling scalable, customizable therapies for drug-resistant bacteria.

Join SynBioBeta, the global community of biological engineers, entrepreneurs, investors, and innovators working to make biology easier to engineer.

For decades, the DNA synthesis world has operated under a quiet rule: this terrible service is just the way it is. Deal with it.

Bacteriophages show therapeutic promise for treating bacterial pathogens including nontuberculous mycobacteria (NTM). A major impediment is the pau...